Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: A multivariate analysis

Journal of Surgical Oncology

Volumn 89, Issue 4, 2005, Pages 211-217

  Stelzner, Sigmar ^a,c   Hellmich, Gunter ^a   Koch, Rainer ^b   Ludwig, Klaus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Colorectal cancer; Palliative treatment; Prognostic factors; Unresectable metastases

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CARCINOMA; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

AGED; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 14744293242     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20196     Document Type: Article

References (35)

1. Joffe J, Gordon PH: Palliative resection for colorectal carcinoma. Dis Colon Rectum 1981;24:355-360.
2. Longo WE, Ballantyne GH, Bilchik AJ, et al.: Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 1988;31: 842-847.
3. Moran MR, Rothenberger DA, Lahr CJ, et al.: Palliation for rectal cancer. Resection? Anastomosis? Arch Surg 1987; 122:640-643.
4. Rosen SA, Buell JF, Yoshida A, et al.: Initial presentation with stage IV colorectal cancer. How aggressive should we be? Arch Surg 2000;135:530-534.
5. Scoggins CR, Meszoely IM, Blanke CD, et al.: Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6:651-657.
6. Sarela AI, Guthrie JA, Seymour MT, et al.: Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001;88:1352-1356.
7. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group: Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial. J Clin Oncol 1992;10:904-911.
8. Scheithauer W, Rosen H, Kornek GV, et al.: Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 1993;306:752-755.
9. Hermanek P, Mansmann U: Criteria for assessment of prognostic factors. Chirurg 2001;72:474-480 [in German].
10. Silverman DT, Murray JL, Smart CR, et al.: Estimated median survival times of patients with colorectal cancer based on experience with 96,745 patients. Am J Surg 1977;133:289-297.
11. Vogt P, Raab R, Ringe B, et al.: Resection of synchronous liver metastases from colorectal cancer. World J Surg 1991;15:62-67.
12. Fong Y, Kemeny N, Paty P, et al.: Treatment of colorectal cancer: Hepatic metastasis. Sem Surg Oncol 1996;12:219-252.
13. Mella J, Biffin A, Radcliffe AG, et al.: Population-based audit of colorectal cancer management in two UK health regions. Br J Surg 1997;84:1731-1736.
14. Johnson WR, McDermott FT, Pihl E, et al.: Operative management in rectal carcinoma. Dis Colon Rectum 1981;24:606-609.
15. Boey H, Choi TK, Wong J, et al.: Carcinoma of the colon and rectum with liver involvement. Surg Gynecol Obstet 1981;153: 864-868.
16. Mäkelä J, Haukipuro K, Laitinen S, et al.: Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846-850.
17. Mahteme H, Påhlman L, Glimelius B, et al.: Prognosis after surgery in patients with incurable rectal cancer: A population-based study. Br J Surg 1996;83:1116-1120.
18. Liu SKM, Church JM, Lavery IC et al.: Operation in patients with incurable colon cancer-Is it worthwhile? Dis Colon Rectum 1997;40:11-14.
19. Görög D, Toth A, Weltner J: Prognosis of untreated liver metastasis from rectal cancer. Acta Chirurgica Hungarica 1997; 36:106-107.
20. Ruo L, Gougoutas C, Paty PB, et al.: Elective bowel resection for incurable stage IV colorectal cancer: Prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722-728.
21. Finan PJ, Marshall RJ, Cooper EH, et al.: Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: A clinical and computer analysis. Br J Surg 1985;72:373-377.
22. Yamamura T, Tsukikawa S, Akaishi O, et al.: Multivariate analysis of the prognostic factors of patients with unresectable synchronous liver metastases from colorectal cancer. Dis Colon Rectum 1997;40:1425-1429.
23. Kessler H, Hermanek P, Jr., Wiebelt H: Operative mortality in carcinoma of the rectum. Results of the German Multicentre Study. Int J Colorect Dis 1993;8:158-166.
24. Rougier P, Milan C, Lazorthes F, et al.: Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 1995;82:1397-1400.
25. Edler L, Heim ME, Quintero C, et al.: Prognostic factors of advanced colorectal cancer patients. Eur J Cancer Clin Oncol 1986;22:1231-1237.
26. Graf W, Glimelius B, Påhlman L, et al.: Determinants of prognosis in advanced colorectal cancer. Eur J Cancer 1991;27:1119-1123.
27. Assersohn L, Norman A, Cunningham D, et al.: Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. Br J Cancer 1999; 79:1800-1805.
28. Massacesi C, Norman A, Price T, et al.: A clinical nomogram for predicting long-term survival in advanced colorectal cancer. Eur J Cancer 2000;36:2044-2052.
29. Massacesi C, Pistilli B, Valeri M, et al.: Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens. Am J Clin Oncol 2002;25:140-148.
30. Lahr CJ, Soong SJ, Cloud G, et al.: Multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1983;1:720-726.
31. Kemeny N, Braun DW: Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status and white blood cell count. Am J Med 1983;74:786-794.
32. Kemeny N, Niedzwiecki D, Shurgot B, et al.: Prognostic variables in patients with hepatic metastases from colorectal cancer. Cancer 1989;63:742-747.
33. Chang AE, Steinberg SM, Culnane M, et al.: Determinants of survival in patients with unresectable colorectal liver metastases. J Surg Oncol 1989;40:245-251.
34. Stangl R, Altendorf-Hofmann A, Charnley RM, et al.: Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-1410.
35. Fountzilas G, Gossios K, Zisiadis A, et al.: Prognostic variables in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy. Med Pediatr Oncol 1996;26: 305-317.